Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles

Biomaterials

Volumn 32, Issue 20, 2011, Pages 4584-4593

  Yang, Hong ^a   Zhuang, Yeming ^a   Sun, Yun ^d   Dai, Antao ^a   Shi Xiangyang, X ^b,c   Wu, Dongmei ^e   Li, Fuyou ^d   Hu, He ^a   Yang, Shiping ^a  

^a SHANGHAI NORMAL UNIVERSITY   (China)

^b DONGHUA UNIVERSITY   (China)

^c UNIVERSITY OF MADEIRA   (Portugal)

^d FUDAN UNIVERSITY   (China)

^e EAST CHINA NORMAL UNIVERSITY   (China)

Author keywords

Dual contrast; Gadolinium labeled; Magnetic resonance imaging; Superparamagnetic iron oxide; Targeted; Tumors

Indexed keywords

A-THERMAL; ARGININE-GLYCINE-ASPARTIC ACIDS; CELL VIABILITY; CONTRAST AGENT; CORE-SHELL NANOPARTICLES; DIETHYLENETRIAMINE PENTA-ACETIC ACIDS; DUAL-CONTRAST; FUNCTIONALIZED; GADOLINIUM COMPLEXES; GD-DTPA; IN-VITRO; INTEGRINS; MOLAR RATIO; MR IMAGING; MULTI-FUNCTIONAL NANOPARTICLES; RELAXIVITY; SILANIZATIONS; SUPERPARAMAGNETIC IRON OXIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; SUPERPARAMAGNETICS; TARGETED; TUMOR CELLS; WATER DISPERSIBLE;

AMINO ACIDS; GADOLINIUM; IRON; IRON OXIDES; NANOMAGNETICS; NANOPARTICLES; ORGANIC ACIDS; PYROLYSIS; RESONANCE; SILICA; SUPERPARAMAGNETISM; TUMORS;

MAGNETIC RESONANCE IMAGING;

ARGINYLGLYCYLASPARTIC ACID; GADOLINIUM PENTETATE; SILICON DIOXIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ARTICLE; BIOCOMPATIBILITY; CELL VIABILITY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG STABILITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR DIAGNOSIS;

CELL LINE; CONTRAST MEDIA; FERRIC COMPOUNDS; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MATERIALS TESTING; MOLECULAR STRUCTURE; NEOPLASMS; PARTICLE SIZE; X-RAY DIFFRACTION;

EID: 79955524007     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.03.018     Document Type: Article

References (39)

1. Ludwig J.A., Weinstein J.N. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 2005, 5:845-856.
2. Beer A., Schwaiger M. Imaging of integrin αvβ3 expression. Cancer Metastasis Rev 2008, 27:631-644.
3. Chen K., Xie J., Xu H., Behera D., Michalski M.H., Biswal S., et al. Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting. Biomaterials 2009, 30:6912-6919.
4. Dechantsreiter M.A., Planker E., Mathä B., Lohof E., Hölzemann G., Jonczyk A., et al. N-methylated cyclic RGD peptides as highly active and selective αVβ3 integrin antagonists. J Med Chem 1999, 42:3033-3040.
5. Wadas T.J., Deng H., Sprague J.E., Zheleznyak A., Weilbaecher K.N., Anderson C.J. Targeting the αvβ3 integrin for small-animal PET/CT of osteolytic bone metastases. J Nucl Med 2009, 50:1873-1880.
6. Haubner R., Decristoforo C. Radiolabelled RGD peptides and peptidomimetics for tumour targeting. Front Biosci 2009, 14:872-886.
7. Borden M.A., Zhang H., Gillies R.J., Dayton P.A., Ferrara K.W. A stimulus-responsive contrast agent for ultrasound molecular imaging. Biomaterials 2008, 29:597-606.
8. Welsher K., Liu Z., Sherlock S.P., Robinson J.T., Chen Z., Daranciang D., et al. A route to brightly fluorescent carbon nanotubes for near-infrared imaging in mice. Nat Nanotechnol 2009, 4:773-780.
9. Xiong L., Chen Z., Tian Q., Cao T., Xu C., Li F. High contrast upconversion luminescence targeted imaging in vivo using peptide-labeled nanophosphors. Anal Chem 2009, 81:8687-8694.
10. Zhang L., Xue H., Gao C., Carr L., Wang J., Chu B., et al. Imaging and cell targeting characteristics of magnetic nanoparticles modified by a functionalizable zwitterionic polymer with adhesive 3,4-dihydroxyphenyl-l-alanine linkages. Biomaterials 2010, 31:6582-6588.
11. Lee J.-H., Lee K., Moon S.H., Lee Y., Park T.G., Cheon J. All-in-one target-cell-specific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery. Angew Chem Int Ed 2009, 48:4174-4179.
12. Aime S., Fasano M., Terreno E. Lanthanide(III) chelates for NMR biomedical applications. Chem Soc Rev 1998, 27:19-29.
13. Raymond K.N., Pierre V.C. Next generation, high relaxivity gadolinium MRI agents. Bioconjug Chem 2004, 16:3-8.
14. Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007, 2:751-760.
15. Cheng Z., Thorek D., Tsourkas A. Gadolinium-conjugated dendrimer nanoclusters as a tumor-targeted T1 magnetic resonance imaging contrast agent. Angew Chem Int Ed 2010, 49:346-350.
16. Nam T., Park S., Lee S.-Y., Park K., Choi K., Song I.C., et al. Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging. Bioconjug Chem 2010, 21:578-582.
17. Rieter W.J., Kim J.S., Taylor K.M.L., An H., Lin W., Tarrant T., et al. Hybrid silica nanoparticles for multimodal imaging. Angew Chem Int Ed 2007, 46:3680-3682.
18. Warsi M.F., Adams R.W., Duckett S.B., Chechik V. Gd-functionalised Au nanoparticles as targeted contrast agents in MRI: relaxivity enhancement by polyelectrolyte coating. Chem Commun 2010, 46:451-453.
19. Manus L.M., Mastarone D.J., Waters E.A., Zhang X.-Q., Schultz-Sikma E.A., MacRenaris K.W., et al. Gd(III)-nanodiamond conjugates for MRI contrast enhancement. Nano Lett 2010, 10:484-489.
20. Lee H., Lee E., Kim D.K., Jang N.K., Jeong Y.Y., Jon S. Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging. J Am Chem Soc 2006, 128:7383-7389.
21. Ma L.L., Feldman M.D., Tam J.M., Paranjape A.S., Cheruku K.K., Larson T.A., et al. Small multifunctional nanoclusters (nanoroses) for targeted cellular imaging and therapy. ACS Nano 2009, 3:2686-2696.
22. Chou S.-W., Shau Y.-H., Wu P.-C., Yang Y.-S., Shieh D.-B., Chen C.-C. In vitro and in vivo studies of FePt nanoparticles for dual modal CT/MRI molecular imaging. J Am Chem Soc 2010, 132:13270-13278.
23. Yang H., Zhuang Y., Hu H., Du X., Zhang C., Shi X., et al. Silica-coated manganese oxide nanoparticles as a platform for targeted magnetic resonance and fluorescence imaging of cancer cells. Adv Funct Mater 2010, 20:1733-1741.
24. Bae K.H., Kim Y.B., Lee Y., Hwang J., Park H., Park T.G. Bioinspired synthesis and characterization of gadolinium-Labeled magnetite nanoparticles for dual contrast T1- and T2-weighted magnetic resonance imaging. Bioconjug Chem 2010, 21:505-512.
25. Choi J.-S., Lee J.-H., Shin T.-H., Song H.-T., Kim E.Y., Cheon J. Self-confirming "AND" logic nanoparticles for fault-free MRI. J Am Chem Soc 2010, 132:11015-11017.
26. Shi X., Wang S.H., Swanson S.D., Ge S., Cao Z., Van Antwerp M.E., et al. Dendrimer-functionalized shell-crosslinked iron oxide nanoparticles for in vivo magnetic resonance imaging of tumors. Adv Mater 2008, 20:1671-1678.
27. Hu F., Wei L., Zhou Z., Ran Y., Li Z., Gao M. Preparation of biocompatible magnetite nanocrystals for in vivo magnetic resonance detection of cancer. Adv Mater 2006, 18:2553-2556.
28. Xie J., Chen K., Lee H.-Y., Xu C., Hsu A.R., Peng S., et al. Ultrasmall c(RGDyK)-coated Fe3O4 nanoparticles and their specific targeting to integrin αvβ3-rich tumor cells. J Am Chem Soc 2008, 130:7542-7543.
29. Huh Y.-M., Jun Y.-W., Song H.-T., Kim S., Choi J.-S., Lee J.-H., et al. In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. J Am Chem Soc 2005, 127:12387-12391.
30. Sun S., Zeng H., Robinson D.B., Raoux S., Rice P.M., Wang S.X., et al. Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. J Am Chem Soc 2004, 126:273-279.
31. Yoon T.-J., Yu K.N., Kim E., Kim J.S., Kim B.G., Yun S.-H., et al. Specific targeting, cell sorting, and bioimaging with smart magnetic silica core-shell nanomaterials. Small 2006, 2:209-215.
32. Koehler F.M., Rossier M., Waelle M., Athanassiou E.K., Limbach L.K., Grass R.N., et al. Magnetic EDTA: coupling heavy metal chelators to metal nanomagnets for rapid removal of cadmium, lead and copper from contaminated water. Chem Commun 2009, 45:4862-4864.
33. Debouttière P.-J., Roux S., Vocanson F., Billotey C., Beuf O., Favre-Réguillon A., et al. Design of gold nanoparticles for magnetic resonance imaging. Adv Funct Mater 2006, 16:2330-2339.
34. Deng C., Tian H., Zhang P., Sun J., Chen X., Jing X. Synthesis and characterization of RGD peptide grafted poly(ethylene glycol)-b-poly(l-lactide)-b-poly(l-glutamic acid) triblock copolymer. Biomacromolecules 2006, 7:590-596.
35. Leng Y., Sato K., Shi Y., Li J.-G., Ishigaki T., Yoshida T., et al. Oxidation-resistant silica coating on gas-phase-reduced iron nanoparticles and influence on magnetic properties. J Phys Chem C 2009, 113:16681-16685.
36. Fan Q.-L., Neoh K.-G., Kang E.-T., Shuter B., Wang S.-C. Solvent-free atom transfer radical polymerization for the preparation of poly(poly(ethyleneglycol) monomethacrylate)-grafted Fe3O4 nanoparticles: synthesis, characterization and cellular uptake. Biomaterials 2007, 28:5426-5436.
37. Villringer A., Rosen B.R., Belliveau J.W., Ackerman J.L., Lauffer R.B., Buxton R.B., et al. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn Reson Med 1988, 6:164-174.
38. Loubeyre P., De Jaegere T., Bosmans H., Miao Y., Ni Y., Landuyt W., et al. Comparison of iron oxide particles (AMI 227) with a gadolinium complex (Gd-DOTA) in dynamic susceptibility contrast MR imagings (FLASH and EPI) for both phantom and rat brain at 1.5 tesla. J Magn Reson Imag 1999, 9:447-453.
39. Gu H., Zheng R.K., Zhang X.X., Xu B. Facile one-pot synthesis of bifunctional heterodimers of nanoparticles: a conjugate of quantum dot and magnetic nanoparticles. J Am Chem Soc 2004, 126:5664-5665.